Literature DB >> 24131182

Angiogenesis in glioblastoma.

Sunit Das, Philip A Marsden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24131182      PMCID： PMC5378489          DOI： 10.1056/NEJMcibr1309402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.

Authors:  Lin Cheng; Zhi Huang; Wenchao Zhou; Qiulian Wu; Shannon Donnola; James K Liu; Xiaoguang Fang; Andrew E Sloan; Yubin Mao; Justin D Lathia; Wang Min; Roger E McLendon; Jeremy N Rich; Shideng Bao
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

2.  Transdifferentiation of glioblastoma cells into vascular endothelial cells.

Authors:  Yasushi Soda; Tomotoshi Marumoto; Dinorah Friedmann-Morvinski; Mie Soda; Fei Liu; Hiroyuki Michiue; Sandra Pastorino; Meng Yang; Robert M Hoffman; Santosh Kesari; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

3.  Glioblastoma stem-like cells give rise to tumour endothelium.

Authors:  Rong Wang; Kalyani Chadalavada; Jennifer Wilshire; Urszula Kowalik; Koos E Hovinga; Adam Geber; Boris Fligelman; Margaret Leversha; Cameron Brennan; Viviane Tabar
Journal:  Nature       Date:  2010-11-21       Impact factor: 49.962

4.  Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

Authors:  Lucia Ricci-Vitiani; Roberto Pallini; Mauro Biffoni; Matilde Todaro; Gloria Invernici; Tonia Cenci; Giulio Maira; Eugenio Agostino Parati; Giorgio Stassi; Luigi Maria Larocca; Ruggero De Maria
Journal:  Nature       Date:  2010-11-21       Impact factor: 49.962

5.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962
  5 in total
  87 in total

1.  pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma.

Authors:  Jingwen Yao; Caleb Hock Pang Tan; Jacob Schlossman; Ararat Chakhoyan; Catalina Raymond; Whitney B Pope; Noriko Salamon; Albert Lai; Matthew Ji; Phioanh L Nghiemphu; Linda M Liau; Timothy F Cloughesy; Benjamin M Ellingson
Journal:  J Neurooncol       Date:  2019-02-26       Impact factor: 4.130

2.  Early imaging marker of progressing glioblastoma: a window of opportunity.

Authors:  Na Tosha N Gatson; Shane P Bross; Yazmin Odia; Gino J Mongelluzzo; Yirui Hu; Laura Lockard; Jesse J Manikowski; Anand Mahadevan; Syed A J Kazmi; Michel Lacroix; Andrew R Conger; Joseph Vadakara; Lakshmi Nayak; T Linda Chi; Minesh P Mehta; Vinay K Puduvalli
Journal:  J Neurooncol       Date:  2020-06-29       Impact factor: 4.130

3.  miR-204 functions as a tumor suppressor gene, at least partly by suppressing CYP27A1 in glioblastoma.

Authors:  Jun Xin; Li-Min Zheng; De-Ke Sun; Xian-Feng Li; Peng Xu; Li-Qiang Tian
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

4.  Decitabine nanoconjugate sensitizes human glioblastoma cells to temozolomide.

Authors:  Yi Cui; Asia Naz; David H Thompson; Joseph Irudayaraj
Journal:  Mol Pharm       Date:  2015-03-18       Impact factor: 4.939

5.  Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.

Authors:  Dipongkor Saha; Hiroaki Wakimoto; Cole W Peters; Slawomir J Antoszczyk; Samuel D Rabkin; Robert L Martuza
Journal:  Clin Cancer Res       Date:  2018-03-29       Impact factor: 12.531

6.  Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686.

Authors:  Jerrold L Boxerman; Zheng Zhang; Yair Safriel; Jeffrey M Rogg; Ronald L Wolf; Suyash Mohan; Helga Marques; A Gregory Sorensen; Mark R Gilbert; Daniel P Barboriak
Journal:  Neuro Oncol       Date:  2018-09-03       Impact factor: 12.300

7.  Possible effects of radiofrequency electromagnetic fields on in vivo C6 brain tumors in Wistar rats.

Authors:  Nihal S Ouadah; Anthony Lecomte; Franck Robidel; Ann Olsson; Isabelle Deltour; Joachim Schüz; Kelly Blazy; Anne-Sophie Villégier
Journal:  J Neurooncol       Date:  2018-11-12       Impact factor: 4.130

8.  MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.

Authors:  Li Hong; Liu Ya-Wei; Wang Hai; Zhou Qiang; Li Jun-Jie; Annie Huang; Qi Song-Tao; Lu Yun-Tao
Journal:  J Neurooncol       Date:  2016-03-12       Impact factor: 4.130

9.  The KDR (VEGFR-2) Genetic Polymorphism Q472H and c-KIT Polymorphism M541L Are Associated With More Aggressive Behaviour in Astrocytic Gliomas.

Authors:  Niyaz Zaman; Serena Santhana Dass; Persephone DU Parcq; Suzanne Macmahon; Lewis Gallagher; Lisa Thompson; Jamshid S Khorashad; Clara LimbÄck-Stanic
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

10.  Combined treatment of fasudil and glutamate decreased the viability of human glioblastoma cells by excitotoxicity through NMDAR in vitro.

Authors:  Mingliang He; Ming Luo; Shu Chen; Kaishu Li; Meiguang Zheng; Yinlun Weng; Rongbiao Pi; Anmin Liu
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.